000 | 01432 a2200421 4500 | ||
---|---|---|---|
005 | 20250513093956.0 | ||
264 | 0 | _c19961011 | |
008 | 199610s 0 0 eng d | ||
022 | _a0149-5992 | ||
024 | 7 |
_a10.2337/diacare.19.4.324 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBode, B W | |
245 | 0 | 0 |
_aReduction in severe hypoglycemia with long-term continuous subcutaneous insulin infusion in type I diabetes. _h[electronic resource] |
260 |
_bDiabetes care _cApr 1996 |
||
300 |
_a324-7 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAlgorithms |
650 | 0 | 4 | _aBlood Glucose Self-Monitoring |
650 | 0 | 4 | _aCross-Over Studies |
650 | 0 | 4 |
_aDiabetes Mellitus, Type 1 _xblood |
650 | 0 | 4 |
_aDiabetic Ketoacidosis _xepidemiology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 |
_aGlycated Hemoglobin _xanalysis |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypoglycemia _xchemically induced |
650 | 0 | 4 | _aIncidence |
650 | 0 | 4 |
_aInsulin _xadverse effects |
650 | 0 | 4 | _aInsulin Infusion Systems |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aPatient Selection |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aSteed, R D | |
700 | 1 | _aDavidson, P C | |
773 | 0 |
_tDiabetes care _gvol. 19 _gno. 4 _gp. 324-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2337/diacare.19.4.324 _zAvailable from publisher's website |
999 |
_c8726280 _d8726280 |